BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frank SA, Nowak MA. Problems of somatic mutation and cancer. Bioessays. 2004;26:291-299. [PMID: 14988930 DOI: 10.1002/bies.20000] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Bauer R, Kaiser M, Stoll E. A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population. PLoS One 2014;9:e111219. [PMID: 25409511 DOI: 10.1371/journal.pone.0111219] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
2 Whitacre JM, Atamas SP. Degeneracy allows for both apparent homogeneity and diversification in populations. Biosystems 2012;110:34-42. [PMID: 22910487 DOI: 10.1016/j.biosystems.2012.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Casás-Selves M, Degregori J. How cancer shapes evolution, and how evolution shapes cancer. Evolution (N Y) 2011;4:624-34. [PMID: 23705033 DOI: 10.1007/s12052-011-0373-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
4 Warth A, Endris V, Stenzinger A, Penzel R, Harms A, Duell T, Abdollahi A, Lindner M, Schirmacher P, Muley T, Dienemann H, Fink L, Morresi-Hauf A, Pfarr N, Weichert W. Genetic changes of non-small cell lung cancer under neoadjuvant therapy. Oncotarget 2016;7:29761-9. [PMID: 27105513 DOI: 10.18632/oncotarget.8858] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
5 Sprouffske K, Merlo LM, Gerrish PJ, Maley CC, Sniegowski PD. Cancer in light of experimental evolution. Curr Biol 2012;22:R762-71. [PMID: 22975007 DOI: 10.1016/j.cub.2012.06.065] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 8.2] [Reference Citation Analysis]
6 Perry EB, Makohon-Moore A, Zheng C, Kaufman CK, Cai J, Iacobuzio-Donahue CA, White RM. Tumor diversity and evolution revealed through RADseq. Oncotarget 2017;8:41792-805. [PMID: 28611298 DOI: 10.18632/oncotarget.18355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
7 Horne SD, Stevens JB, Abdallah BY, Liu G, Bremer SW, Ye CJ, Heng HH. Why imatinib remains an exception of cancer research. J Cell Physiol 2013;228:665-70. [DOI: 10.1002/jcp.24233] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
8 Sachs RK, Hlatky L. A Rapid-Mutation Approximation for Cell Population Dynamics. Bull Math Biol 2010;72:359-74. [DOI: 10.1007/s11538-009-9450-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Wunderlich V. Early references to the mutational origin of cancer. International Journal of Epidemiology 2007;36:246-7. [DOI: 10.1093/ije/dyl272] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
10 Willmore KE, Hallgrímsson B. Within Individual Variation. Variation. Elsevier; 2005. pp. 191-218. [DOI: 10.1016/b978-012088777-4/50012-0] [Cited by in Crossref: 13] [Article Influence: 0.8] [Reference Citation Analysis]
11 Lean C, Plutynski A. The evolution of failure: explaining cancer as an evolutionary process. Biol Philos 2016;31:39-57. [DOI: 10.1007/s10539-015-9511-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Germain P. Cancer cells and adaptive explanations. Biol Philos 2012;27:785-810. [DOI: 10.1007/s10539-012-9334-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
13 West J, Hasnain Z, Mason J, Newton PK. The prisoner's dilemma as a cancer model. Converg Sci Phys Oncol 2016;2:035002. [PMID: 29177084 DOI: 10.1088/2057-1739/2/3/035002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Crespi BJ, Summers K. Positive selection in the evolution of cancer. Biol Rev Camb Philos Soc 2006;81:407-24. [PMID: 16762098 DOI: 10.1017/S1464793106007056] [Cited by in Crossref: 68] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
15 Zhou P, Chen X, Shi K, Qu H, Xia J. The characteristics, tumorigenicities and therapeutics of cancer stem cells based on circRNAs. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153822] [Reference Citation Analysis]
16 Bjerkvig R, Johansson M, Miletic H, Niclou SP. Cancer stem cells and angiogenesis. Semin Cancer Biol. 2009;19:279-284. [PMID: 19818406 DOI: 10.1016/j.semcancer.2009.09.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
17 Radford IR, Lobachevsky PN. Clustered DNA lesion sites as a source of mutations during human colorectal tumourigenesis. Mutat Res 2008;646:60-8. [PMID: 18824008 DOI: 10.1016/j.mrfmmm.2008.08.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Queller DC, Strassmann JE. Beyond society: the evolution of organismality. Philos Trans R Soc Lond B Biol Sci 2009;364:3143-55. [PMID: 19805423 DOI: 10.1098/rstb.2009.0095] [Cited by in Crossref: 218] [Cited by in F6Publishing: 146] [Article Influence: 18.2] [Reference Citation Analysis]
19 Hartung T, Sabbioni E. Alternative in vitro assays in nanomaterial toxicology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:545-73. [PMID: 21766468 DOI: 10.1002/wnan.153] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
20 Lee J, Müller P, Sengupta S, Gulukota K, Ji Y. Bayesian inference for intratumour heterogeneity in mutations and copy number variation. J R Stat Soc Ser C Appl Stat 2016;65:547-63. [PMID: 28461708 DOI: 10.1111/rssc.12136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
21 Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006;6:924-935. [PMID: 17109012 DOI: 10.1038/nrc2013] [Cited by in Crossref: 1058] [Cited by in F6Publishing: 871] [Article Influence: 66.1] [Reference Citation Analysis]
22 Chao EC, Lipkin SM. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res. 2006;34:840-852. [PMID: 16464822 DOI: 10.1093/nar/gkj489] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
23 Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell. 2006;21:689-700. [PMID: 16507366 DOI: 10.1016/j.molcel.2006.01.013] [Cited by in Crossref: 483] [Cited by in F6Publishing: 458] [Article Influence: 30.2] [Reference Citation Analysis]
24 Crespi B, Summers K. Evolutionary biology of cancer. Trends Ecol Evol 2005;20:545-52. [PMID: 16701433 DOI: 10.1016/j.tree.2005.07.007] [Cited by in Crossref: 163] [Cited by in F6Publishing: 134] [Article Influence: 9.6] [Reference Citation Analysis]
25 Valant J, Drobne D. Biological reactivity of TiO2 nanoparticles assessed by ex vivo testing. Protoplasma 2012;249:835-42. [PMID: 21688199 DOI: 10.1007/s00709-011-0298-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lv XG, Dong WG. Advances in understanding tumor evolution. Shijie Huaren Xiaohua Zazhi 2010; 18(20): 2127-2131 [DOI: 10.11569/wcjd.v18.i20.2127] [Reference Citation Analysis]
27 Preston BD, Albertson TM, Herr AJ. DNA replication fidelity and cancer. Semin Cancer Biol. 2010;20:281-293. [PMID: 20951805 DOI: 10.1016/j.semcancer.2010.10.009] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
28 Ramm SA, Schärer L. The evolutionary ecology of testicular function: size isn't everything: The evolutionary ecology of testicular function. Biol Rev 2014;89:874-88. [DOI: 10.1111/brv.12084] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
29 Wodarz D, Goel A, Komarova NL. Effect of cell cycle duration on somatic evolutionary dynamics. Evol Appl 2017;10:1121-9. [PMID: 29151865 DOI: 10.1111/eva.12518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
30 He D, Chen Y, Li H, Furuya M, Ikehata H, Uehara Y, Komura J, Mak TW, Ono T. Role of the Msh2 gene in genome maintenance and development in mouse fetuses. Mutat Res 2012;734:50-5. [PMID: 22465156 DOI: 10.1016/j.mrfmmm.2012.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Rankin DJ, Bargum K, Kokko H. The tragedy of the commons in evolutionary biology. Trends Ecol Evol 2007;22:643-51. [PMID: 17981363 DOI: 10.1016/j.tree.2007.07.009] [Cited by in Crossref: 263] [Cited by in F6Publishing: 190] [Article Influence: 17.5] [Reference Citation Analysis]
32 Strinkovsky L, Havkin E, Shalom-Feuerstein R, Savir Y. Spatial correlations constrain cellular lifespan and pattern formation in corneal epithelium homeostasis. Elife 2021;10:e56404. [PMID: 33433326 DOI: 10.7554/eLife.56404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Schärer L, Da Lage JL, Joly D. Evolution of testicular architecture in the Drosophilidae: a role for sperm length. BMC Evol Biol 2008;8:143. [PMID: 18477397 DOI: 10.1186/1471-2148-8-143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
34 Plutynski A. Cancer and the goals of integration. Stud Hist Philos Biol Biomed Sci 2013;44:466-76. [PMID: 23582848 DOI: 10.1016/j.shpsc.2013.03.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
35 Ishibashi M, Tamura H, Ogata K. Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironment. Leuk Res 2011;35:1449-52. [PMID: 21757231 DOI: 10.1016/j.leukres.2011.06.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
36 Capp J. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development. Bioessays 2005;27:1277-85. [DOI: 10.1002/bies.20326] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
37 Chen X, Zhang Y, Yan J, Sadiq R, Chen T. miR-34a suppresses mutagenesis by inducing apoptosis in human lymphoblastoid TK6 cells. Mutat Res Genet Toxicol Environ Mutagen 2013;758:35-40. [PMID: 24025418 DOI: 10.1016/j.mrgentox.2013.08.010] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Spencer SL, Gerety RA, Pienta KJ, Forrest S. Modeling somatic evolution in tumorigenesis. PLoS Comput Biol 2006;2:e108. [PMID: 16933983 DOI: 10.1371/journal.pcbi.0020108] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
39 Hartung T, Daston G. Are In Vitro Tests Suitable for Regulatory Use? Toxicological Sciences 2009;111:233-7. [DOI: 10.1093/toxsci/kfp149] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 8.3] [Reference Citation Analysis]
40 Gottlieb B, Beitel LK, Trifiro M. Will knowledge of human genome variation result in changing cancer paradigms? Bioessays 2007;29:678-85. [PMID: 17563087 DOI: 10.1002/bies.20595] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
41 DeGregori J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res 2011;71:3739-44. [PMID: 21610109 DOI: 10.1158/0008-5472.CAN-11-0342] [Cited by in Crossref: 78] [Cited by in F6Publishing: 39] [Article Influence: 7.1] [Reference Citation Analysis]
42 Uygun K, Matthew HW, Huang Y. Investigation of metabolic objectives in cultured hepatocytes. Biotechnol Bioeng 2007;97:622-37. [PMID: 17058287 DOI: 10.1002/bit.21237] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
43 Naugler CT. Population genetics of cancer cell clones: possible implications of cancer stem cells. Theor Biol Med Model 2010;7:42. [PMID: 21062473 DOI: 10.1186/1742-4682-7-42] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
44 Komarova NL, Wu L, Baldi P. The fixed-size Luria-Delbruck model with a nonzero death rate. Math Biosci 2007;210:253-90. [PMID: 17583754 DOI: 10.1016/j.mbs.2007.04.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
45 Heng HH. Cancer genome sequencing: The challenges ahead. Bioessays 2007;29:783-94. [DOI: 10.1002/bies.20610] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
46 Frank SA. Genetic variation in cancer predisposition: mutational decay of a robust genetic control network. Proc Natl Acad Sci U S A 2004;101:8061-5. [PMID: 15141087 DOI: 10.1073/pnas.0400561101] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
47 Yu XJ, Fang F, Tang CL, Yao L, Yu L, Yu L. dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum Mutat. 2011;32:E2308-E2316. [PMID: 21936021 DOI: 10.1002/humu.21595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
48 Miura S, Vu T, Deng J, Buturla T, Oladeinde O, Choi J, Kumar S. Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data. Sci Rep 2020;10:3498. [PMID: 32103044 DOI: 10.1038/s41598-020-59006-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Pasmooij AM, Pas HH, Bolling MC, Jonkman MF. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. J Clin Invest 2007;117:1240-8. [PMID: 17476356 DOI: 10.1172/JCI30465] [Cited by in Crossref: 75] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
50 Kudlow BA, Kennedy BK, Monnat RJ Jr. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 2007;8:394-404. [PMID: 17450177 DOI: 10.1038/nrm2161] [Cited by in Crossref: 204] [Cited by in F6Publishing: 165] [Article Influence: 13.6] [Reference Citation Analysis]
51 Pepper JW, Scott Findlay C, Kassen R, Spencer SL, Maley CC. Cancer research meets evolutionary biology. Evol Appl 2009;2:62-70. [PMID: 25567847 DOI: 10.1111/j.1752-4571.2008.00063.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
52 Bankhead A 3rd, Magnuson NS, Heckendorn RB. Cellular automaton simulation examining progenitor hierarchy structure effects on mammary ductal carcinoma in situ. J Theor Biol 2007;246:491-8. [PMID: 17335852 DOI: 10.1016/j.jtbi.2007.01.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
53 Sprouffske K, Aguilar-Rodríguez J, Sniegowski P, Wagner A. High mutation rates limit evolutionary adaptation in Escherichia coli. PLoS Genet 2018;14:e1007324. [PMID: 29702649 DOI: 10.1371/journal.pgen.1007324] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
54 Bankhead A, Heckendorn RB. Using evolvable genetic cellular automata to model breast cancer. Genet Program Evolvable Mach 2007;8:381-93. [DOI: 10.1007/s10710-007-9042-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
55 Mcdonald EK, Rasmussen H, Forsyth C, Keshavarzian A. The In vivo Foundations for In vitro Testing of Functional Foods. In: Bordenave N, Ferruzzi MG, editors. Functional Foods and Beverages. Hoboken: John Wiley & Sons, Inc.; 2018. pp. 15-51. [DOI: 10.1002/9781118823309.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Aanen DK. Developmental Biology. How a long-lived fungus keeps mutations in check. Science 2014;346:922-3. [PMID: 25414293 DOI: 10.1126/science.1261401] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
57 Ostrow SL, Barshir R, DeGregori J, Yeger-Lotem E, Hershberg R. Cancer evolution is associated with pervasive positive selection on globally expressed genes. PLoS Genet 2014;10:e1004239. [PMID: 24603726 DOI: 10.1371/journal.pgen.1004239] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
58 Capp JP. Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability. Genetics 2010;185:395-404. [PMID: 20606014 DOI: 10.1534/genetics.110.118190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
59 Cotton S. Condition-dependent mutation rates and sexual selection. Journal of Evolutionary Biology 2009;22:899-906. [DOI: 10.1111/j.1420-9101.2008.01683.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Miura S, Huuki LA, Buturla T, Vu T, Gomez K, Kumar S. Computational enhancement of single-cell sequences for inferring tumor evolution. Bioinformatics 2018;34:i917-26. [PMID: 30423071 DOI: 10.1093/bioinformatics/bty571] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
61 Foo J, Leder K, Michor F. Stochastic dynamics of cancer initiation. Phys Biol 2011;8:015002. [PMID: 21301064 DOI: 10.1088/1478-3975/8/1/015002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
62 Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, de Rooij DG, Wilkie AO. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci U S A 2005;102:6051-6. [PMID: 15840724 DOI: 10.1073/pnas.0500267102] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 6.2] [Reference Citation Analysis]
63 Dingli D, Pacheco JM, Traulsen A. Multiple mutant clones in blood rarely coexist. Phys Rev E Stat Nonlin Soft Matter Phys 2008;77:021915. [PMID: 18352059 DOI: 10.1103/PhysRevE.77.021915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
64 Mackenzie IC. Stem cell properties and epithelial malignancies. Eur J Cancer. 2006;42:1204-1212. [PMID: 16644206 DOI: 10.1016/j.ejca.2006.01.041] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
65 Reiter JG, Bozic I, Allen B, Chatterjee K, Nowak MA. The effect of one additional driver mutation on tumor progression. Evol Appl 2013;6:34-45. [PMID: 23396615 DOI: 10.1111/eva.12020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
66 Grunewald TG, Herbst SM, Heinze J, Burdach S. Understanding tumor heterogeneity as functional compartments--superorganisms revisited. J Transl Med. 2011;9:79. [PMID: 21619636 DOI: 10.1186/1479-5876-9-79] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
67 Soto AM, Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm? Bioessays 2004;26:1097-107. [PMID: 15382143 DOI: 10.1002/bies.20087] [Cited by in Crossref: 179] [Cited by in F6Publishing: 154] [Article Influence: 9.9] [Reference Citation Analysis]